Population-based estimates for the prevalence of multiple sclerosis in the US

JAMA Neurology

2023-05-15

(Press-News.org) About The Study: In this national population-based cohort study of multiple sclerosis (MS) prevalence, researchers found that the distribution of MS in the United States has become more racially and ethnically diverse. White individuals continued to have the highest prevalence of MS followed by Black individuals, individuals from other races, and Hispanic individuals.

Authors: Mitchell T. Wallin, M.D., M.P.H., of the University of Maryland School of Medicine in Washington, D.C., is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamaneurol.2023.1135)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2023.1135?guestAccessKey=36b0723d-0001-49e7-82cd-02ba388fbfd2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051523

END

ELSE PRESS RELEASES FROM THIS DATE:

Risk of Parkinson disease among service members at Marine Corps Base Camp Lejeune

2023-05-15

About The Study: This study of 340,000 service members found that the risk of Parkinson disease was 70% higher in veterans who were stationed at Marine Corps Base Camp Lejeune, North Carolina, during 1975-1985 when the water supply was contaminated with the solvent trichloroethylene and other volatile organic compounds. The findings suggest that exposure to trichloroethylene in water may increase the risk of Parkinson disease; millions worldwide have been and continue to be exposed to this ubiquitous environmental contaminant. Authors: Samuel M. Goldman, ...

New study using novel approach for glioblastoma treatment shows promising results, extending survival

2023-05-15

TORONTO - A new international study published in Nature Medicine and presented as a late-breaking abstract at the American Association of Neurological Surgeons (AANS) annual conference, shows great promise for patients with glioblastoma. Drs. Farshad Nassiri and Gelareh Zadeh, neurosurgeons at the University Health Network (UHN) in Toronto, published the results of a Phase 1/2 clinical trial investigating the safety and effectiveness of a novel therapy which combines the injection of an oncolytic virus – a virus that targets and kills ...

Finding ‘vault’: Unravelling the mysteries of p62-bodies and the cellular recycling pathway

2023-05-15

Our body functioning is delicately balanced between the synthesis and breakdown of various cellular components. When these cellular components grow old or get damaged, they are digested by a process called “autophagy”—literally, “self-eating.” This process not only helps in the elimination of toxic wastes, but also helps to deliver building blocks for the synthesis of new cellular macromolecules. Thus, autophagy serves as the body's cellular cleaning and recycling system. Researchers have long been studying the ...

Comprehensive analysis of single plant cells provides new insights into natural product biosynthesis

2023-05-15

Plants are impressive in their diversity, but especially in the variety of metabolites they produce. Many plant natural products are highly complex molecules, such as the alkaloids vincristine and vinblastine, which are produced by the Madagascar periwinkle Catharanthus roseus. These two substances are already indispensable in cancer therapy. Researchers are very interested in finding out which individual biosynthetic steps are required to form the complex molecules. "Currently, these compounds are still obtained in very small quantities from the plant's leaf extract. We can learn from the plant how this compound is produced and use this knowledge ...

Dementia study reveals how toxic proteins spread through brain

2023-05-15

Fresh insights into the spread of damaging proteins that build up in the brains of people with Alzheimer’s disease could hold the key to stopping the condition progressing, a study says. Researchers have discovered that synapses, which send essential signals through the brain, are also transporting toxic proteins known as tau around the brain. Large clumps of the protein tau – called tangles – form in brain cells and are one of the defining features of Alzheimer’s disease. As these tangles spread through the brain during the disease there is a decline in ...

Combined delivery of engineered virus with immunotherapy is safe and improves outcomes in subset of patients with glioblastoma

2023-05-15

HOUSTON ― Intratumoral delivery of an engineered oncolytic virus (DNX-2401) targeting glioblastoma (GBM) cells combined with subsequent immunotherapy was safe and improved survival outcomes in a subset of patients with recurrent GBM, according to results from a multi-institutional Phase I/II clinical trial co-led by researchers at The University of Texas MD Anderson Cancer Center and the University of Toronto. The study, published today in Nature Medicine, met its primary safety endpoint and demonstrated the combination was well tolerated overall with no dose-limiting toxicities. The study did not meet its primary efficacy endpoint of objective response rate, but ...

Mass General Brigham investigators identify new genetic variant protective against Alzheimer's disease

2023-05-15

A single patient can spark new research questions and provide answers about a disease. And when a new case is identified, investigators can make connections between them that can lead to even more powerful and persuasive ideas about cause and treatment. In a publication today in Nature Medicine, an international team led by investigators from two Mass General Brigham hospitals — Massachusetts General Hospital (MGH) and Mass Eye and Ear — reports on a new case of a patient with a genetic predisposition for developing early-onset Alzheimer’s disease who remained cognitively intact until his late 60s. Through clinical assessments ...

Out of this world control on Ice Age cycles

2023-05-15

A research team, composed of climatologists and an astronomer, have used an improved computer model to reproduce the cycle of ice ages (glacial periods) 1.6 to 1.2 million years ago. The results show that the glacial cycle was driven primarily by astronomical forces in quite a different way than it works in the modern age. These results will help us to better understand the past, present, and future of ice sheets and the Earth’s climate. Earth’s orbit around the Sun and its spin axis orientation change slowly over time, due to the pull of gravity from the Sun, the Moon, and other planets. These astronomical forces affect the environment on Earth due to changes in ...

Methylated cyclodextrin effectively prevents the crystallization of supersaturated drugs

2023-05-15

In the medicine market, most newly introduced drugs and drug candidates show poor water solubility, which prevents their absorption in the body. This, in turn, limits their therapeutic efficiency. Solubilizing agents such as cyclodextrins (CDs) are commonly employed to enhance their solubility. CDs have a cyclic structure featuring a hydrophilic exterior and a hydrophobic cavity inside that can enclose drug molecules to form inclusion complexes. However, solubilization does not necessarily enhance drug adsorption in the body, since the solubilized drugs cannot ...

Translating science into impact: Cane-Bridge Foundation donates $1M to Boyce Thompson Institute for Innovative Translational Research Program

2023-05-15

Ithaca, NY (May 15, 2023) - Today, the Boyce Thompson Institute (BTI) is taking a significant step forward in its mission to bridge the gap between scientific discovery and real-world application. Thanks to a generous $1M gift from the Cane-Bridge Foundation, BTI has launched an innovative translational program called "Project Vault!" to propel plant science discoveries into applications that tackle global life science challenges. "The Cane-Bridge Foundation's support is vital to accelerate ...

LAST 30 PRESS RELEASES:

CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury

Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1

Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce